Overview
Suliat Nurudeen is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Nurudeen is rated as an Experienced provider by MediFind in the treatment of Li-Fraumeni Syndrome. Her top areas of expertise are Breast Cancer, Fibroadenoma, Giant Mammary Hamartoma, Mastectomy, and Lymphadenectomy. Dr. Nurudeen is currently accepting new patients.
Her clinical research consists of co-authoring 9 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
22 S Green St, Baltimore, MD 21201
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Virginia Cancer Specialists, P.C.
David Weintritt is a General Surgeon in Leesburg, Virginia. Dr. Weintritt is rated as a Distinguished provider by MediFind in the treatment of Li-Fraumeni Syndrome. His top areas of expertise are Breast Cancer, Intraductal Papilloma, Paget Disease of the Breast, Angiosarcoma, and Lymphadenectomy. Dr. Weintritt is currently accepting new patients.
Maryland Oncology Hematology PA
Surupa Sen Gupta is a General Surgeon and a Surgical Oncologist in Laurel, Maryland. Dr. Sen Gupta is rated as a Distinguished provider by MediFind in the treatment of Li-Fraumeni Syndrome. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, and Giant Mammary Hamartoma. Dr. Sen Gupta is currently accepting new patients.
Virginia Cancer Specialists, P.C.
Elizabeth Feldman is a General Surgeon and a Surgical Oncologist in Leesburg, Virginia. Dr. Feldman is rated as a Distinguished provider by MediFind in the treatment of Li-Fraumeni Syndrome. Her top areas of expertise are Fibroadenoma, Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, and Lymphadenectomy. Dr. Feldman is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Nurudeen isDistinguished. Learn about Breast Cancer.
- Advanced
- FibroadenomaDr. Nurudeen isAdvanced. Learn about Fibroadenoma.
- Giant Mammary HamartomaDr. Nurudeen isAdvanced. Learn about Giant Mammary Hamartoma.
- Intraductal PapillomaDr. Nurudeen isAdvanced. Learn about Intraductal Papilloma.
- Paget Disease of the BreastDr. Nurudeen isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- AngiosarcomaDr. Nurudeen isExperienced. Learn about Angiosarcoma.
- BRCA Positive Breast CancerDr. Nurudeen isExperienced. Learn about BRCA Positive Breast Cancer.
- Breast Cancer in MenDr. Nurudeen isExperienced. Learn about Breast Cancer in Men.
- Breast LumpDr. Nurudeen isExperienced. Learn about Breast Lump.
- FrostbiteDr. Nurudeen isExperienced. Learn about Frostbite.
- HER-2 Positive Breast CancerDr. Nurudeen isExperienced. Learn about HER-2 Positive Breast Cancer.